Bladder Cancer
US Clinical Practice Patterns of Intravesical Chemotherapy for BCG-Unresponsive and BCG-Exposed Non-muscle Invasive Bladder Cancer.
November 1, 2023
Artificial Intelligence Reveals Distinct Prognostic Subgroups of Muscle-Invasive Bladder Cancer on Histology Images.
October 31, 2023
Tumor Markers as Predictors of Acute Kidney Injury Incidence and Staging of the Muscle-Invasive Bladder Cancer Receiving Chemoradiation Therapy.
October 31, 2023
Recent Patterns in Global Incidence and Mortality for Bladder Cancer - Expert Commentary
October 30, 2023
The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040.
October 30, 2023
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma.
October 30, 2023
Role of Maximal Transurethral Resection Preceding Partial Cystectomy for Muscle-Invasive Bladder Cancer.
October 30, 2023
Bladder cancer.
October 30, 2023
Enfortumab Vedotin Versus Chemotherapy for Advanced Urothelial Carcinoma - Expert Commentary
October 26, 2023
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma?
October 26, 2023
Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma.
October 26, 2023
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer.
October 25, 2023
Familial Risk and Interaction With Smoking and Alcohol Consumption in Bladder Cancer: A Population-Based Cohort Study.
October 24, 2023